The University of Kansas Cancer Center 2020 ASCO Highlights

https://www.kucancercenter.org/

 

The University of Kansas Cancer Center 2020 ASCO Highlights
J

2020 ASCO Highlights on NSCLC Targeted Therapy: T-DXd for HER2-Mutated, Capmatinib for MET-Amplified, Selpercatinib (LOXO-292) for RET-Altered, Adjuvant Osimertinib for EGFR+ Disease

By The University of Kansas Cancer Center 2020 ASCO Highlights FEATURING Jun Zhang
By The University of Kansas Cancer Center 2020 ASCO Highlights FEATURING Jun Zhang
0 views
September 9, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn
Videos
10:04
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on ES-SCLC: Does the Addition of Anti-CTLA-4 Tremel…

Feat. J. Zhang
13:10
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO NSCLC Highlights: Can We Consider Nivo + Ipi a Novel Chemo…

Feat. J. Zhang
08:14
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Highlights on NSCLC Targeted Therapy: T-DXd for HER2-Mutat…

Feat. J. Zhang
08:28
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on mCRC: Does T-DXd Have Potential in HER2+ Disease…

Feat. A. Saeed
12:44
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on Rectal Cancer: Should We Consider Total Neoadjuv…

Feat. A. Saeed
11:42
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on MSI-H mCRC: Is Pembrolizumab More Beneficial Tha…

Feat. A. Saeed
09:40
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on Gastroesophageal Cancer: Is Cabozantinib + Durva…

Feat. A. Saeed
09:55
The University of Kansas Cancer Center 2020 ASCO Highlights

ASCO 2020 Updates on Epithelial Ovarian Cancer: How Effective Is Sec…

Feat. A. Jewell, C. Salyer
07:24
The University of Kansas Cancer Center 2020 ASCO Highlights

ASCO 2020 Updates on Cervical Cancer and GTD: Sequential Chemo vs. R…

Feat. A. Jewell, C. Salyer
14:55
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on Neoadjuvant Therapy in TNBC: Does Sequential AC/…

Feat. P. Sharma
06:08
The University of Kansas Cancer Center 2020 ASCO Highlights

2020 ASCO Update on Neoadjuvant Therapy in TNBC: How Effective Is th…

Feat. P. Sharma
18:35
The University of Kansas Cancer Center 2020 ASCO Highlights

ASCO 2020 Symptoms and Survivorship Highlights: Does Early Palliativ…

Feat. E. Wulff-Burchfield